- AEGR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $57.4 million.
- AEGR has traded 1.9 million shares today.
- AEGR is up 3% today.
- AEGR was down 41% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AEGR with the Ticky from Trade-Ideas. See the FREE profile for AEGR NOW at Trade-Ideas More details on AEGR: Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. Currently there are 6 analysts that rate Aegerion Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Aegerion Pharmaceuticals has been 1.0 million shares per day over the past 30 days. Aegerion has a market cap of $1.0 billion and is part of the health care sector and drugs industry. The stock has a beta of -0.22 and a short float of 51.5% with 3.50 days to cover. Shares are down 71.5% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.